Nebulized ketamine versus nebulized dexmedetomidine for pain control after endoscopic nasal surgery
Official title: Pre-emptive Analgesia Using Nebulized Ketamine Versus Nebulized Dexmedetomidine in Endoscopic Nasal Surgeries
Run by Sohag University · NCT07056582 · Data updated 2026-11-12
This trial will test whether inhaled (nebulized) ketamine or inhaled dexmedetomidine provides better pain relief after endoscopic nasal surgery for adults aged 20 to 60.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 60 Years |
| Sex | All |
| Enrollment | 105 (estimated) |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Status | Recruiting |
| Started | April 14, 2025 |
| Main results expected | October 20, 2025 |
| Study ends | October 20, 2025 |
| Registry record updated | July 9, 2025 |
| Trial ID | NCT07056582 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 20–60 years old scheduled for endoscopic nasal surgery who are ASA physical status I–II with BMI between 18 and 30, not pregnant or breastfeeding, and without significant organ or psychiatric disease.
✕Probably not a fit
Patients with advanced respiratory, renal, hepatic, neurological, or psychiatric disease, pregnant or nursing women, those with drug allergies, recent CNS depressant or analgesic use, or unstable blood pressure/heart rate are unlikely to be eligible or to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants scheduled for endoscopic nasal surgery receive a pre-emptive nebulized dose of ketamine, nebulized dexmedetomidine, or saline before anesthesia, and postoperative pain scores and analgesic consumption are recorded. The trial enrolls ASA I–II adults aged 20–60 with BMI 18–30 and excludes those with major organ disease, pregnancy, recent CNS depressant use, or hemodynamic instability. Pain is measured at standardized postoperative time points using validated pain scales, and vital signs are monitored for drug-related effects. The goal is to identify which nebulized agent gives better immediate postoperative analgesia and whether either reduces opioid requirements.
Why it matters
Potential benefit: If successful, one of the nebulized drugs could offer better immediate pain relief after endoscopic nasal surgery and reduce the need for opioid painkillers.
How similar studies have gone: Smaller studies and case series have reported that nebulized ketamine or dexmedetomidine can reduce postoperative pain in airway and minor surgical settings, but direct head-to-head comparisons are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients between the ages of 20 and 60, * both sexes, * American Society of Anesthesiologists physical status I to II * BMI ≥18≤30 kg/m² Exclusion Criteria: * Patient refusal. * patients with advanced respiratory, renal, hepatic, neurological, or psychiatric disease, pregnant or nursing women. * patients with a history of allergies to any study drugs. * patients who had used central nervous system depressants or analgesics within the previous 24 hours. * patients with hypertension, hypotension, or bradycardia.
Where it's running
-
Sohag university hospital
Sohag, Egypt Recruiting
Study contacts
- Study coordinator: Ahmed T Abdelhameed, Resident
- Email: ahmedthanocloser460@gmail.com
- Phone: 01012833899
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Trauma registry at Sohag University Hospital
This study tests the creation of a trauma registry in the emergency department to collect data on injured adults admitted with polytrauma at Sohag University Hospital.
-
Prevalence of Myocardial Bridging and its relation to Coronary Plaques on MDCT
This study tests how common myocardial bridging is and whether it relates to coronary plaque in patients undergoing coronary CT angiography.
-
Septoplasty: see if it changes headache symptoms
This study tests whether septoplasty can change headache severity in adults with septal deviation and headache.
-
Predicting SLE Flares with Patient Reports and Machine Learning
Aims to test a low-cost, patient-reported outcome–based machine learning tool to see if it can detect lupus flares early and support care, especially in settings with limited resources.
-
Is geographic mismatch linked to short-term major heart problems after long drug-eluting stent placement?
This study checks whether geographic mismatch can predict short-term major adverse cardiovascular events after a long drug-eluting stent is placed in the coronary arteries.
-
Biomarkers to predict no-reflow after opening the heart’s artery in STEMI patients
This study tests whether immune-inflammatory and metabolic biomarkers can predict coronary no-reflow after primary PCI in adults with STEMI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.